Cargando…
Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
Chronic kidney disease (CKD) patients are at an increased risk of cardiovascular disease (CVD) and statins may not be protective in advanced CKD. The reasons for the limited efficacy of statins in advanced CKD are unclear, but statins may increase plasma levels of the highly atherogenic molecule lip...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577764/ https://www.ncbi.nlm.nih.gov/pubmed/33123354 http://dx.doi.org/10.1093/ckj/sfaa001 |